Loading...
Tamoxifen induction of angiogenic factor expression in endometrium
Tamoxifen is the current therapy of choice for patients with oestrogen receptor positive breast cancer, and it is currently under evaluation as a prophylactic for women at high risk of developing the disease. However, tamoxifen is also known to induce proliferative changes in the endometrium increas...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group
2002
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2375303/ https://ncbi.nlm.nih.gov/pubmed/11875740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600157 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|